June 12, 2018

This week, our Clinical Text discusses both loss of beta cell function and beta cell mass, and how granulation can mask loss of mass. The interesting thing about this week’s installment is the overwhelming evidence that treating to a goal A1c is not the most important thing for a type 2 patient. Check out what the authors think could possibly be more important.

Dave Joffe

Editor-in-chief